Oncology

Latest News

February 9th 2012

Heart Disease May Be a Risk Factor for Prostate Cancer

February 9th 2012

Robert Gamble Discusses Patient-Centered Medical Homes Option for Cancer Patients

February 7th 2012

Poor Guidelines Compliance Suspected Cause of Most Metastatic GCT Relapses

February 6th 2012

Abbreviated Radiotherapy Shows Promise in Prostate Cancer

February 3rd 2012

Most Common Treatment for Prostate Cancer Not Best Value

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Watch Now

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

CME Content

On-Demand Virtual Symposium

From Strict Avoidance to Tailored Therapies: Transforming Food Allergy Care

1.5 Credits / Allergy, Immunology

On-Demand Virtual Symposium

The Evolving Strategies for Managing nAMD and DME: Empowering Managed Care Decisions for Improved Patient Outcomes

1.5 Credits / Endocrinology, Diabetes & Metabolism, Ophthalmology/Optometry

On-Demand Webinar

Managing Schizophrenia: Evidence-Based Care and Optimizing Value of New and Emerging Therapies

1.0 Credit / Psychiatry

Virtual Symposium

Closing Gaps in CLL Care: Managed Care Insights and Strategies

1.5 Credit / Hematologic Cancer, Oncology

On-Demand Webinar

Revolutionizing Acute Pain Relief: Emerging Non-Opioid Therapies and the Essential Role of Pharmacists

1.5 Credit / Pain Management/Opioids

On-Demand Webinar

Overview and Burden of Migraine

0.5 Credit / Neurology

On-Demand Webinar

The Role of the Pharmacist Migraine Management

0.5 Credit / Neurology

On-Demand Webinar

The Evolving Treatment Landscape of Migraine

0.5 Credit / Neurology

On-Demand Webinar

Evidence-Based Guidelines Point to Leap in Care for Hypertrophic Cardiomyopathy

1.0 Credit / Cardiology

On-Demand Webinar

ASH Annual Meeting Coverage: Highlighting the Recent Updates in TKI Use in the Treatment of CML – Insights and Application for Managed Care

1.0 Credit / Oncology, Hematology, Hematologic Cancer

Online Article

New and Approved: FDA’s 2024 Drug Lineup

1.5 Credits / General Pharmacy

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

On-Demand Virtual Symposium

Leveraging Managed Care to Optimize Patient Outcomes: Integrating Novel Treatments in Schizophrenia

1.5 Credits / Neurology, Psychiatry

On-Demand Virtual Symposium

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

On-Demand Virtual Symposium

Overcoming Operational and Clinical Barriers in Multiple Myeloma: Managed Care Strategies for Antibody-Based Regimens

1.5 Credits / Hematologic Cancer, Hematology, Oncology

On-Demand Virtual Symposium

Exploring Therapeutic Advances in Myelofibrosis and Key Considerations for Effective Management

1.5 Credits / Oncology, Hematology

On-Demand Virtual Symposium

Driving Better Outcomes in Hypertrophic Cardiomyopathy: A Managed Care Imperative

1.5 Credits / Cardiology

On-Demand Virtual Symposium

Optimizing the Uptake of Long-Acting Injectables in HIV Treatment and Prevention: Considerations for Managed Care

1.5 Credits / HIV/AIDS, Infectious Disease

On-Demand Virtual Symposium

Harnessing Data-Driven Insights and Innovations to Enhance AMD and DME Management: Strategic Approaches for Managed Care

1.5 Credits / Ophthalmology/Optometry

On-Demand Virtual Symposium

Navigating the Advancements in Oral Therapy Options in HR+ Metastatic Breast Cancer

1.5 Credits / Breast Cancer, Oncology, Women's Health

On-Demand Virtual Symposium

Navigating the Changing Treatment Paradigm of Metabolic Dysfunction-Associated Steatohepatitis: A Guide for Managed Care Pharmacists

1.5 Credits / Endocrinology, Diabetes & Metabolism, Gastroenterology

On-Demand Virtual Symposium

Managed Care Approaches and Models for Equitable Access to Innovations in Major Depressive Disorder Treatment

1.5 Credits / Psychiatry

On-Demand Virtual Symposium

Evaluating the Effectiveness and Value of Novel Nonhormonal Treatments in the Management of Menopause-Related Vasomotor Symptoms

1.5 Credits / Women's Health

On-Demand Virtual Symposium

Updated Guidance and Managed Care Strategies to Optimize Respiratory Syncytial Virus Vaccination Coverage

1.5 Credits / Immunization, Infectious Disease, Pulmonology

On-Demand Virtual Symposium

Leveraging Biologics and Immunotherapies in the Management of Food Allergies

1.5 Credits / Immunology, Allergy

On-Demand Virtual Symposium

Advancing Care in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Optimizing Outcomes With Emerging Therapies

1.5 Credits / Ophthalmology/Optometry

On-Demand Virtual Symposium

The Evolving Landscape of Transthyretin Amyloidosis Cardiomyopathy: New Therapies and Treatment Strategies

1.5 Credits / Cardiology, Rare Diseases

On-Demand Virtual Symposium

Reflecting on the Real-World Use of Biologic Therapy in Asthma Management

1.5 Credits / Immunology, Pulmonology

On-Demand Virtual Symposium

Advancing Cystic Fibrosis Management: The Evolving Role of Specialty and Managed Care Pharmacists

1.5 Credits / Pulmonology

On-Demand Virtual Symposium

Pulmonary Arterial Hypertension: Real-World Applications of New Therapies and Management Strategies

1.5 Credits / Pulmonology, Cardiology, Rare Diseases

On-Demand Virtual Symposium

Targeting Chronic Rhinosinusitis With Nasal Polyps With Biologics: Optimizing Outcomes and Reducing Health Care Burden

1.5 Credits / Immunology

On-Demand Virtual Symposium

Emerging Treatment Options for Inflammatory Bowel Disease: A Focus on IL-23 Pathway Inhibition

1.5 Credits / Gastroenterology, Immunology

On-Demand Virtual Symposium

Transforming Metabolic Dysfunction-Associated Steatohepatitis Management: Pharmacist Considerations for the Evolving Treatment Landscape

1.5 Credits / Gastroenterology

On-Demand Webinar

Innovations in Inflammatory Bowel Disease Therapy: How IL-23 Inhibitors Are Shaping Treatment and Managed Care Approaches

1.5 Credits / Gastroenterology, Immunology

On-Demand Webinar

The Expanding Therapeutic Landscape in IgA Nephropathy: Applying Evidence-Based Strategies and Guideline Updates for Managed Care

1.0 Credit / Immunology, Nephrology

On-Demand Webinar

Leveraging Novel Therapies to Transform Demodex Blepharitis Care (Pharmacy Technician Credit)

1.5 Credit / Ophthalmology/Optometry

On-Demand Webinar

Leveraging Novel Therapies to Transform Demodex Blepharitis Care

1.5 Credit / Ophthalmology/Optometry

On-Demand Webinar

The Changing Paradigm in Pain Management and Supporting Access to Novel Therapies

1.0 Credit / Pain Management/Opioids

On-Demand Webinar

The Expanding Therapeutic Landscape in IgA Nephropathy: A Case-Based Exploration of Optimized Patient Outcomes

1.0 Credit / Immunology, Nephrology

On-Demand Webinar

Opioids, Pain Management, and Substance Use Disorder: A Practical Overview

2.0 Credits / Pain Management/Opioids

Study: Pricey Surgery Robots Lack Clear Benefits

January 31st 2012

N.J. Cancer Docs Form Network

January 30th 2012

Prostate Cancer Screenings: The Debate Continues

January 30th 2012

Researchers who set off a firestorm in 2009 when they questioned the need for all adult men to undergo annual prostate cancer screenings have updated their findings.

Prostate Cancer Study Proves Drug Delays Disease Progression

January 24th 2012

New Test Offers Greater Accuracy in Early Detection of Colorectal Cancer

January 20th 2012

Dr. Adil Daud Discusses Zelboraf and Yervoy for the Treatment of Metastatic Melanoma

January 19th 2012

Systematic Review of Comparative Effectiveness Data for Oncology Orphan Drugs

ByMindy M. Cheng, MS,Scott D. Ramsey, MD, PhD,Emily Beth Devine, PharmD, MBA, PhD,Louis P. Garrison, PhD,Brian W. Bresnahan, PhD,David L. Veenstra, PharmD, PhD

January 19th 2012

This study critically assessed the published clinical and economic evidence supporting oncology orphan drugs marketed in the United States.

Dr. Michelle Melisko Discusses Access to Care for Breast Cancer Patients

January 16th 2012

New Indicator May Help Identify Patients With Increased Risk From Throat Cancer

January 16th 2012

Significant Cost Savings Associated With Emergence Of Prospective Surveillance Model As Standard Of Care For Breast Cancer Treatment

January 9th 2012

Early Palliative Care Improves Quality of Life in NSCLC

December 30th 2011

Johns Hopkins Gets More Than $8 Million to Further Cancer Research and Treatments

December 29th 2011

Following the Patient's Lead

December 28th 2011

ASCO Picks Top Advances in Cancer Treatment

December 28th 2011

Dr. Susan Urba Discusses Cost Concerns for Treatment of Chemotherapy-Induced Nausea

December 22nd 2011

Dr. Susan Urba Discusses Preventive Care for Patients With Chemotherapy-Induced Nausea

December 22nd 2011

Cost Savings in Inpatient Oncology Through an Integrative Medicine Approach

ByBenjamin Kligler, MD, MPH,Peter Homel, PhD,Louis B. Harrison, MD,Hanniel D. Levenson, MS,Jeanne B. Kenney, RN, BSN, HN-BC,Woodson Merrell, MD

December 22nd 2011

An approach including yoga, holistic nursing, and a "healing environment" can decrease medication use, resulting in substantial cost savings in care of inpatient oncology patients.

Cancer Vaccines: New Approaches

December 21st 2011

Cancer Screening May Be Overdone in Older Adults

December 15th 2011

American Cancer Society Changes Its Screening Guideline Process

December 14th 2011

Breast Cancer Survivors Prefer Oncologist Follow-Up

December 13th 2011

ONC Pushing for Standards to Increase Interoperability

December 12th 2011

Dr. Ravi Vij Discusses Benefits/Efficacy of Carfilzomib and Revlimid

December 6th 2011

ASCO Calls on Congress to Fix Flawed Medicare Payment System

December 2nd 2011

U.S. House Oversight and Government Reform Subcommittee Holds Hearing on Drug Shortages

December 1st 2011

Oncology

Latest News

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

CME Content

From Strict Avoidance to Tailored Therapies: Transforming Food Allergy Care

The Evolving Strategies for Managing nAMD and DME: Empowering Managed Care Decisions for Improved Patient Outcomes

Managing Schizophrenia: Evidence-Based Care and Optimizing Value of New and Emerging Therapies

Closing Gaps in CLL Care: Managed Care Insights and Strategies

Revolutionizing Acute Pain Relief: Emerging Non-Opioid Therapies and the Essential Role of Pharmacists

Overview and Burden of Migraine

The Role of the Pharmacist Migraine Management

The Evolving Treatment Landscape of Migraine

Evidence-Based Guidelines Point to Leap in Care for Hypertrophic Cardiomyopathy

ASH Annual Meeting Coverage: Highlighting the Recent Updates in TKI Use in the Treatment of CML – Insights and Application for Managed Care

New and Approved: FDA’s 2024 Drug Lineup

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Leveraging Managed Care to Optimize Patient Outcomes: Integrating Novel Treatments in Schizophrenia

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

Overcoming Operational and Clinical Barriers in Multiple Myeloma: Managed Care Strategies for Antibody-Based Regimens

Exploring Therapeutic Advances in Myelofibrosis and Key Considerations for Effective Management

Driving Better Outcomes in Hypertrophic Cardiomyopathy: A Managed Care Imperative

Optimizing the Uptake of Long-Acting Injectables in HIV Treatment and Prevention: Considerations for Managed Care

Harnessing Data-Driven Insights and Innovations to Enhance AMD and DME Management: Strategic Approaches for Managed Care

Navigating the Advancements in Oral Therapy Options in HR+ Metastatic Breast Cancer

Navigating the Changing Treatment Paradigm of Metabolic Dysfunction-Associated Steatohepatitis: A Guide for Managed Care Pharmacists

Managed Care Approaches and Models for Equitable Access to Innovations in Major Depressive Disorder Treatment

Evaluating the Effectiveness and Value of Novel Nonhormonal Treatments in the Management of Menopause-Related Vasomotor Symptoms

Updated Guidance and Managed Care Strategies to Optimize Respiratory Syncytial Virus Vaccination Coverage

Leveraging Biologics and Immunotherapies in the Management of Food Allergies

Advancing Care in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Optimizing Outcomes With Emerging Therapies

The Evolving Landscape of Transthyretin Amyloidosis Cardiomyopathy: New Therapies and Treatment Strategies

Reflecting on the Real-World Use of Biologic Therapy in Asthma Management

Advancing Cystic Fibrosis Management: The Evolving Role of Specialty and Managed Care Pharmacists

Pulmonary Arterial Hypertension: Real-World Applications of New Therapies and Management Strategies

Targeting Chronic Rhinosinusitis With Nasal Polyps With Biologics: Optimizing Outcomes and Reducing Health Care Burden

Emerging Treatment Options for Inflammatory Bowel Disease: A Focus on IL-23 Pathway Inhibition

Transforming Metabolic Dysfunction-Associated Steatohepatitis Management: Pharmacist Considerations for the Evolving Treatment Landscape

Innovations in Inflammatory Bowel Disease Therapy: How IL-23 Inhibitors Are Shaping Treatment and Managed Care Approaches

The Expanding Therapeutic Landscape in IgA Nephropathy: Applying Evidence-Based Strategies and Guideline Updates for Managed Care

Leveraging Novel Therapies to Transform Demodex Blepharitis Care (Pharmacy Technician Credit)

Leveraging Novel Therapies to Transform Demodex Blepharitis Care

The Changing Paradigm in Pain Management and Supporting Access to Novel Therapies

The Expanding Therapeutic Landscape in IgA Nephropathy: A Case-Based Exploration of Optimized Patient Outcomes

Opioids, Pain Management, and Substance Use Disorder: A Practical Overview

Study: Pricey Surgery Robots Lack Clear Benefits

N.J. Cancer Docs Form Network

Prostate Cancer Screenings: The Debate Continues

Prostate Cancer Study Proves Drug Delays Disease Progression

New Test Offers Greater Accuracy in Early Detection of Colorectal Cancer

Dr. Adil Daud Discusses Zelboraf and Yervoy for the Treatment of Metastatic Melanoma

Systematic Review of Comparative Effectiveness Data for Oncology Orphan Drugs

Dr. Michelle Melisko Discusses Access to Care for Breast Cancer Patients

New Indicator May Help Identify Patients With Increased Risk From Throat Cancer

Significant Cost Savings Associated With Emergence Of Prospective Surveillance Model As Standard Of Care For Breast Cancer Treatment

Early Palliative Care Improves Quality of Life in NSCLC

Johns Hopkins Gets More Than $8 Million to Further Cancer Research and Treatments

Following the Patient's Lead

ASCO Picks Top Advances in Cancer Treatment

Dr. Susan Urba Discusses Cost Concerns for Treatment of Chemotherapy-Induced Nausea

Dr. Susan Urba Discusses Preventive Care for Patients With Chemotherapy-Induced Nausea

Cost Savings in Inpatient Oncology Through an Integrative Medicine Approach

Cancer Vaccines: New Approaches

Cancer Screening May Be Overdone in Older Adults

American Cancer Society Changes Its Screening Guideline Process

Breast Cancer Survivors Prefer Oncologist Follow-Up

ONC Pushing for Standards to Increase Interoperability

Dr. Ravi Vij Discusses Benefits/Efficacy of Carfilzomib and Revlimid

ASCO Calls on Congress to Fix Flawed Medicare Payment System

U.S. House Oversight and Government Reform Subcommittee Holds Hearing on Drug Shortages

Trending on AJMC

Abemaciclib Plus Endocrine Therapy Improves Overall Survival in High-Risk Early Breast Cancer

Medicare State Rankings Reveal Stark Differences in Access, Quality, and Affordability

First-Line Zongertinib Yields Strong Responses in Patients With Advanced HER2-Mutant NSCLC

Real-World Data Show Preventive Nirsevimab Reduces Infant RSV Hospitalizations

New Biomarkers, Drug Targets Identified for Colorectal Cancer